Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.
Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S. Kada Mohammed S, et al. Among authors: coutant c. Breast Cancer Res Treat. 2023 Jan;197(2):377-385. doi: 10.1007/s10549-022-06807-w. Epub 2022 Nov 23. Breast Cancer Res Treat. 2023. PMID: 36417042 Free PMC article.
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors.
Frati A, Chereau E, Coutant C, Bezu C, Antoine M, Chopier J, Daraï E, Uzan S, Gligorov J, Rouzier R. Frati A, et al. Among authors: coutant c. Breast Cancer Res Treat. 2012 Apr;132(2):601-7. doi: 10.1007/s10549-011-1897-0. Epub 2011 Dec 9. Breast Cancer Res Treat. 2012. PMID: 22160638
Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.
De Gournay E, Guyomard A, Coutant C, Boulet S, Arveux P, Causeret S, Gouy S, Padeano MM, Loustalot C, Sauzedde JM, Smail M, Combier JP, Chevillote P, Rosburger C, Bonnetain F, Fraisse J, Dabakuyo-Yonli TS. De Gournay E, et al. Among authors: coutant c. Br J Cancer. 2013 Nov 26;109(11):2783-91. doi: 10.1038/bjc.2013.658. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169352 Free PMC article. Clinical Trial.
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.
Humbert O, Berriolo-Riedinger A, Cochet A, Gauthier M, Charon-Barra C, Guiu S, Desmoulins I, Toubeau M, Dygai-Cochet I, Coutant C, Fumoleau P, Brunotte F. Humbert O, et al. Among authors: coutant c. Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):416-27. doi: 10.1007/s00259-013-2616-3. Epub 2013 Nov 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24258007
Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
Degrolard-Courcet E, Sokolowska J, Padeano MM, Guiu S, Bronner M, Chery C, Coron F, Lepage C, Chapusot C, Loustalot C, Jouve JL, Hatem C, Ferrant E, Martin L, Coutant C, Baurand A, Couillault G, Delignette A, El Chehadeh S, Lizard S, Arnould L, Fumoleau P, Callier P, Mugneret F, Philippe C, Frebourg T, Jonveaux P, Faivre L. Degrolard-Courcet E, et al. Among authors: coutant c. Eur J Hum Genet. 2014 Aug;22(8):979-87. doi: 10.1038/ejhg.2013.278. Epub 2013 Dec 4. Eur J Hum Genet. 2014. PMID: 24301060 Free PMC article. Review.
HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.
Humbert O, Cochet A, Riedinger JM, Berriolo-Riedinger A, Arnould L, Coudert B, Desmoulins I, Toubeau M, Dygai-Cochet I, Guiu S, Coutant C, Fumoleau P, Brunotte F. Humbert O, et al. Among authors: coutant c. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1525-33. doi: 10.1007/s00259-014-2739-1. Epub 2014 Mar 20. Eur J Nucl Med Mol Imaging. 2014. PMID: 24647576
275 results